Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Randomized controlled trial assessing the effect of simvastatin in primary biliary cirrhosis.

Cash WJ, O'Neill S, O'Donnell ME, McCance DR, Young IS, McEneny J, McDougall NI, Callender ME.

Liver Int. 2013 Sep;33(8):1166-74. doi: 10.1111/liv.12191.

PMID:
23672463
2.

Cardiovascular and inflammatory effects of simvastatin therapy in patients with COPD: a randomized controlled trial.

John ME, Cockcroft JR, McKeever TM, Coward WR, Shale DJ, Johnson SR, Thornton JG, Harrison TW, Knox AJ, Bolton CE.

Int J Chron Obstruct Pulmon Dis. 2015 Jan 29;10:211-21. doi: 10.2147/COPD.S76061.

3.

Simvastatin in primary biliary cirrhosis: effects on serum lipids and distinct disease markers.

Ritzel U, Leonhardt U, Näther M, Schäfer G, Armstrong VW, Ramadori G.

J Hepatol. 2002 Apr;36(4):454-8.

PMID:
11943414
4.

LDL-lipids from patients with hypercholesterolaemia and Alzheimer's disease are inflammatory to microvascular endothelial cells: mitigation by statin intervention.

Dias HK, Brown CL, Polidori MC, Lip GY, Griffiths HR.

Clin Sci (Lond). 2015 Dec;129(12):1195-206. doi: 10.1042/CS20150351.

5.

First United Kingdom Heart and Renal Protection (UK-HARP-I) study: biochemical efficacy and safety of simvastatin and safety of low-dose aspirin in chronic kidney disease.

Baigent C, Landray M, Leaper C, Altmann P, Armitage J, Baxter A, Cairns HS, Collins R, Foley RN, Frighi V, Kourellias K, Ratcliffe PJ, Rogerson M, Scoble JE, Tomson CR, Warwick G, Wheeler DC.

Am J Kidney Dis. 2005 Mar;45(3):473-84.

PMID:
15754269
6.

Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high-risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy - The IN-CROSS study.

Farnier M, Averna M, Missault L, Vaverkova H, Viigimaa M, Massaad R, Vandormael K, Johnson-Levonas AO, Brudi P.

Int J Clin Pract. 2009 Apr;63(4):547-59. doi: 10.1111/j.1742-1241.2009.02022.x.

PMID:
19222610
7.

Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.

Lewin AJ, Kipnes MS, Meneghini LF, Plotkin DJ, Perevozskaya IT, Shah S, Maccubbin DL, Mitchel YB, Tobert JA; Simvastatin/Thiazolidinedione Study Group..

Clin Ther. 2004 Mar;26(3):379-89.

PMID:
15110130
10.

Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial.

Jula A, Marniemi J, Huupponen R, Virtanen A, Rastas M, Rönnemaa T.

JAMA. 2002 Feb 6;287(5):598-605.

PMID:
11829698
11.

Simvastatin-induced changes in circulating oxidized low-density lipoprotein in different types of dyslipidemia.

Tavridou A, Efthimiadis A, Efthimiadis I, Manolopoulos VG.

Heart Vessels. 2010 Jul;25(4):288-93. doi: 10.1007/s00380-009-1202-x.

PMID:
20676836
12.

Achievement of specified lipid and high-sensitivity C-reactive protein levels with two statins in Chinese patients with hypercholesterolaemia.

Ding C, Hu M, Wu YJ, Tomlinson B.

Lipids Health Dis. 2015 Sep 13;14:107. doi: 10.1186/s12944-015-0116-0.

13.
14.

Ezetimibe and simvastatin reduce inflammation, disease activity, and aortic stiffness and improve endothelial function in rheumatoid arthritis.

Mäki-Petäjä KM, Booth AD, Hall FC, Wallace SM, Brown J, McEniery CM, Wilkinson IB.

J Am Coll Cardiol. 2007 Aug 28;50(9):852-8.

15.

A 52-week, multicenter, randomized, parallel-group, double-blind, double-dummy study to assess the efficacy of atorvastatin and simvastatin in reaching low-density lipoprotein cholesterol and triglyceride targets: the treat-to-target (3T) study.

Olsson AG, Eriksson M, Johnson O, Kjellström T, Lanke J, Larsen ML, Pedersen T, Tikkanen MJ, Wiklund O; 3T Study Investigators..

Clin Ther. 2003 Jan;25(1):119-38.

PMID:
12637115
16.
17.

Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial.

Goldberg AC, Sapre A, Liu J, Capece R, Mitchel YB; Ezetimibe Study Group..

Mayo Clin Proc. 2004 May;79(5):620-9.

PMID:
15132403
18.

Randomized placebo-controlled study of the effects of simvastatin on haemostatic variables, lipoproteins and free fatty acids. The Oxford Cholesterol Study Group.

Mitropoulos KA, Armitage JM, Collins R, Meade TW, Reeves BE, Wallendszus KR, Wilson SS, Lawson A, Peto R.

Eur Heart J. 1997 Feb;18(2):235-41.

19.

Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men.

Bennett S, Sager P, Lipka L, Melani L, Suresh R, Veltri E; Ezetimibe Study Group..

J Womens Health (Larchmt). 2004 Dec;13(10):1101-7.

PMID:
15650343
20.

Efficacy and safety of combination simvastatin and colesevelam in patients with primary hypercholesterolemia.

Knapp HH, Schrott H, Ma P, Knopp R, Chin B, Gaziano JM, Donovan JM, Burke SK, Davidson MH.

Am J Med. 2001 Apr 1;110(5):352-60.

PMID:
11286949
Items per page

Supplemental Content

Support Center